Carteolol
Back to searchMolecule Structure
Scientific Name
Carteolol
Description of the Drug
Carteolol is a beta adrenergic antagonist used to treat arrhythmia, angina, hypertension, and glaucoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00521
http://www.drugbank.ca/drugs/DB00521
Brand Name(s)
Not Available
Company Owner(s)
Apotex Inc, Sandoz Inc, Bausch And Lomb Inc, Abbvie Inc, Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Adrenergic receptor beta | PROTEIN FAMILY | ANTAGONIST | CHEMBL2094118 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL23721779 | SCHEMBL24810 | |
PharmGKB | PA164768736 | ||
Human Metabolome Database | HMDB0014662 | ||
DrugBank | DB00521 | ||
PubChem: Thomson Pharma | 14849226 | ||
PubChem | 2583 | ||
LINCS | LSM-1541 | ||
Nikkaji | J13.087G | ||
BindingDB | 50040065 | ||
EPA CompTox Dashboard | DTXSID3022746 | ||
DrugCentral | 520 | ||
ChemicalBook | CB0268673 | ||
Guide to Pharmacology | 7142 | ||
rxnorm | OCUPRESS | CARTEOLOL | CARTEOLOL HYDROCHLORIDE |
KEGG Ligand | C06874 | ||
ChEBI | 3437 |